+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Artificial Organ Bank Market - Global Forecast 2026-2032- Product Image
Artificial Organ Bank Market - Global Forecast 2026-2032- Product Image
Sale

Artificial Organ Bank Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904639
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Artificial Organ Bank Market is projected to reach USD 13.04 Billion in 2026. It is expected to continue growing at a CAGR of 7.25%, reaching USD 19.92 Billion by 2032.

An artificial organ bank is emerging as a strategic healthcare infrastructure model that connects artificial organs, bioartificial organs, implantable devices, engineered tissues, organ preservation systems, and digital matching platforms into a more reliable transplant and organ replacement pathway. Demand is grounded in a measurable public health gap: the U.S. Health Resources & Services Administration reports more than 100,000 people on the national transplant waiting list and about 17 deaths each day while waiting for an organ. Similar pressures are amplified globally by aging populations, diabetes, cardiovascular disease, liver disease, respiratory failure, and chronic kidney disease.

The opportunity is not limited to one device category. It spans total artificial hearts, ventricular assist devices, artificial kidney concepts, artificial pancreas systems, bioengineered grafts, regenerative medicine, 3D bioprinting, xenotransplantation research, cryopreservation, machine perfusion, and AI-enabled logistics. As transplant systems move from scarcity management toward precision allocation and manufactured organ substitutes, the artificial organ bank becomes a core platform for resilience, equity, and clinical continuity.

Transformative Shifts in the Artificial Organ Bank Landscape

The artificial organ bank landscape is shifting from experimental innovation to integrated clinical infrastructure. Advances in biomaterials, decellularized scaffolds, stem-cell-derived tissues, organ-on-chip validation, immunomodulation, and additive manufacturing are accelerating the movement from passive storage toward living, monitored, and quality-controlled organ replacement ecosystems. At the same time, hypothermic and normothermic machine perfusion are extending assessment windows for donor organs and shaping quality protocols that are directly relevant to future artificial and bioartificial organ inventories.

Regulation is also reshaping commercialization. The U.S. FDA, European Medicines Agency, EU Medical Device Regulation, and national health technology assessment bodies increasingly require strong evidence on safety, durability, biocompatibility, cybersecurity, sterility assurance, and real-world performance. This raises development complexity but improves clinical credibility, creating an advantage for organizations that combine clinical validation, traceable supply chains, interoperable data systems, and post-market evidence generation.

Cumulative Impact of Artificial Intelligence on Artificial Organ Banking

Artificial intelligence is becoming a cumulative force across artificial organ banking by improving patient-device matching, transplant prioritization, inventory planning, post-implant monitoring, quality assurance, and adverse-event detection. The FDA has authorized hundreds of AI-enabled medical devices across healthcare, demonstrating regulatory momentum for software-driven clinical decision support, although artificial organ applications still require rigorous validation, bias monitoring, cybersecurity controls, and human clinical oversight.

In practice, AI can help integrate imaging, blood type, HLA data, comorbidity profiles, device performance telemetry, preservation metrics, infection-risk indicators, and logistics constraints into more precise allocation and maintenance decisions. The highest-value use cases are not replacing clinicians but reducing avoidable delays, flagging device deterioration, predicting demand by geography, supporting digital twins for personalized organ replacement planning, and strengthening long-term surveillance after implantation.

Key Regional Insights for Artificial Organ Bank Adoption

Asia-Pacific is gaining momentum through large patient populations, rising chronic disease prevalence, expanding transplant centers, and government support for biotechnology in China, Japan, India, South Korea, Australia, and ASEAN economies. The region is also supported by strong electronics, robotics, biomaterials, and regenerative medicine capabilities, although affordability, reimbursement variation, and access gaps remain important barriers. North America remains the most mature innovation hub because of advanced transplant networks, established organ procurement systems, FDA pathways, academic medical centers, reimbursement depth, and active medtech financing. Europe benefits from coordinated transplant organizations, strong biomedical engineering, established tissue and cell governance, and the EU regulatory push toward traceability, safety, and lifecycle monitoring.

Latin America is led by improving transplant capacity in Brazil, Mexico, Argentina, Chile, and Colombia, but access remains uneven across public and private systems, and specialized infrastructure is concentrated in major cities. The Middle East is investing in specialty hospitals, medical tourism, and national transplant programs, especially across GCC economies, where diabetes, cardiovascular disease, and kidney disease create a strong clinical rationale for advanced organ replacement technologies. Africa continues to face infrastructure, specialist workforce, and affordability constraints, yet selected urban centers in South Africa, Egypt, Kenya, and Nigeria are building clinical capabilities that could support future artificial organ bank partnerships, regional training models, and referral-based implant programs.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN presents an important access opportunity as Indonesia, Thailand, Malaysia, Singapore, Vietnam, and the Philippines expand specialist care, transplant services, and private hospital networks, though reimbursement diversity and uneven transplant infrastructure require localized entry models. The GCC is positioned for premium artificial organ and advanced implant adoption because of high healthcare spending, diabetes and cardiovascular disease burden, government-led hospital modernization, and growing emphasis on medical self-sufficiency. The European Union offers scale through harmonized safety expectations, MDR compliance, cross-border research funding, tissue and cell governance, and data protection requirements that encourage traceable, evidence-led artificial organ bank models.

BRICS economies provide volume-driven demand, domestic manufacturing ambitions, and significant chronic disease burdens, making them central to future affordability and localization strategies across artificial organs, preservation systems, and bioengineered tissues. G7 countries remain primary centers for clinical trials, reimbursement innovation, regulatory science, transplant research, and advanced device adoption due to mature healthcare infrastructure and strong academic networks. NATO markets overlap with many high-income health systems and create opportunities for resilient medical supply chains, dual-use logistics, emergency preparedness planning, and standardized procurement frameworks for high-acuity organ replacement technologies.

Key Country Insights for Artificial Organ Bank Market Prioritization

The United States anchors demand with the world’s most visible transplant waiting list data, a mature FDA framework, advanced organ procurement networks, and strong adoption of cardiac support, renal support, and diabetes management technologies. Canada emphasizes regulated access, public reimbursement discipline, and specialized transplant centers, while Mexico and Brazil show rising need supported by expanding hospital capacity and chronic disease management programs; Brazil is particularly important because of its large public transplant system and established national organ donation framework. In Latin America, these country-level dynamics point to a pathway where artificial organ bank adoption is likely to begin in advanced tertiary hospitals before expanding through public-private referral networks.

In Europe, the United Kingdom, Germany, France, Italy, and Spain combine advanced clinical expertise with rigorous evidence requirements, established transplant networks, and strong medical technology assessment processes, while Spain is globally recognized for organ donation system performance. Russia maintains scientific and clinical capacity but faces procurement, technology access, and geopolitical constraints that can affect advanced implant availability. China and India represent the largest long-term volume opportunities due to population scale, chronic kidney disease, diabetes, cardiovascular disease, and expanding specialty hospital infrastructure, while Japan, South Korea, and Australia offer sophisticated regulatory systems, robotics, regenerative medicine expertise, and high-quality hospital infrastructure for premium artificial organ bank solutions.

Actionable Recommendations for Artificial Organ Bank Leaders

Industry leaders should prioritize clinically validated product portfolios that combine artificial organs, preservation platforms, digital registries, and AI-enabled monitoring rather than standalone devices. Commercial success will depend on proof of survival benefit, quality-of-life improvement, biocompatibility, infection control, device longevity, equitable access, and total cost-of-care reduction.

Organizations should invest early in regulatory strategy, post-market surveillance, cybersecurity, interoperable data architecture, and evidence generation aligned with transplant workflow. Partnerships with transplant centers, payers, tissue banks, bioprinting labs, public health agencies, and logistics providers can accelerate adoption, while regional manufacturing and service hubs can reduce supply risk for high-acuity implants, preservation systems, consumables, and device maintenance.

Research Methodology for Evidence-Based Market Intelligence

This executive summary is developed using a structured secondary research methodology that triangulates public data from health authorities, transplant registries, regulatory agencies, peer-reviewed journals, clinical trial repositories, patent activity, public disclosures, and recognized global health sources. Core reference inputs include HRSA/OPTN, WHO-linked transplant observatories, FDA device databases, EMA and EU regulatory publications, NIH resources, OECD health indicators, and national transplant agencies.

The analysis evaluates demand drivers, technology readiness, clinical adoption barriers, regulatory context, reimbursement feasibility, regional infrastructure, supply chain resilience, and competitive positioning. Insights are validated through cross-source comparison, exclusion of unsupported claims, and emphasis on evidence-based trends rather than speculative market sizing, market share, or forecasting.

Conclusion: Artificial Organ Banks as Next-Generation Healthcare Infrastructure

The artificial organ bank market is moving toward a platform-based future where engineered organs, advanced preservation, AI-enabled matching, and real-world performance data work together to reduce transplant scarcity. The strongest pathways will come from clinically credible technologies that solve measurable capacity gaps while meeting strict safety, durability, cybersecurity, and reimbursement standards.

Organizations that align innovation with transplant workflow, regional access needs, and long-term patient monitoring will be best positioned to lead. As healthcare systems seek alternatives to organ shortages, artificial organ banks can become a defining infrastructure layer for next-generation replacement medicine and a critical bridge between transplantation, regenerative medicine, and intelligent medical device ecosystems.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Artificial Organ Bank Market, by Organ Type
7.1. Introduction
7.2. Heart
7.3. Intestine
7.4. Kidney
7.5. Liver
7.6. Lung
7.7. Pancreas
8. Artificial Organ Bank Market, by Technology
8.1. Introduction
8.2. 3D Bioprinting
8.2.1. Extrusion Bioprinting
8.2.2. Inkjet Bioprinting
8.2.3. Laser Assisted Bioprinting
8.3. Cell Culture
8.4. Decellularization
8.5. Scaffold Based Technology
8.5.1. Ceramic Scaffold
8.5.2. Natural Polymer Scaffold
8.5.3. Synthetic Polymer Scaffold
9. Artificial Organ Bank Market, by Material Type
9.1. Introduction
9.2. Biological
9.2.1. Allogenic
9.2.2. Autologous
9.3. Synthetic
9.3.1. Composite
9.3.2. Polymer
10. Artificial Organ Bank Market, by Application
10.1. Introduction
10.2. Pharmaceutical Testing
10.3. Research
10.4. Transplantation
11. Artificial Organ Bank Market, by End User
11.1. Introduction
11.2. Hospitals
11.3. Organ Transplant Centers
11.4. Research Institutes
12. Artificial Organ Bank Market, by Region
12.1. Asia-Pacific
12.2. Europe
12.3. North America
12.4. Latin America
12.5. Africa
12.6. Middle East
13. Artificial Organ Bank Market, by Group
13.1. NATO
13.2. G7
13.3. BRICS
13.4. European Union
13.5. ASEAN
13.6. GCC
14. Artificial Organ Bank Market, by Country
14.1. China
14.2. United States
14.3. Japan
14.4. India
14.5. Germany
14.6. United Kingdom
14.7. Australia
14.8. France
14.9. South Korea
14.10. Italy
14.11. Canada
14.12. Russia
14.13. Brazil
14.14. Mexico
14.15. Spain
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. FPNV Positioning Matrix, 2025
15.3. Market Concentration Analysis, 2025
15.3.1. Concentration Ratio (CR)
15.3.2. Herfindahl Hirschman Index (HHI)
15.4. Recent Developments & Impact Analysis, 2025
15.5. Product Portfolio Analysis, 2025
15.6. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Abiomed, Inc.
16.2. Artivion, Inc.
16.3. Asahi Kasei Medical Co., Ltd.
16.4. B. Braun Melsungen AG
16.5. Baxter International Inc.
16.6. Berlin Heart GmbH
16.7. BiVACOR Pty Ltd
16.8. Boston Scientific Corporation
16.9. CARMAT SA
16.10. CELLINK AB
16.11. Cochlear Limited
16.12. CryoLife, Inc.
16.13. Edwards Lifesciences Corporation
16.14. Fresenius Medical Care AG & Co. KGaA
16.15. Getinge AB
16.16. Jarvik Heart, Inc.
16.17. LivaNova PLC
16.18. Medtronic plc
16.19. Miromatrix Medical Inc.
16.20. Nipro Corporation
16.21. Organovo Holdings, Inc.
16.22. OrganOx Limited by Terumo Corporation
16.23. SynCardia Systems, LLC
16.24. TransMedics, Inc.
16.25. Xvivo Perfusion AB
16.26. Zimmer Biomet Holdings Inc.
List of Figures
FIGURE 1. GLOBAL ARTIFICIAL ORGAN BANK MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL ARTIFICIAL ORGAN BANK MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL ARTIFICIAL ORGAN BANK MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL ARTIFICIAL ORGAN BANK MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 17. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 19. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 21. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL ARTIFICIAL ORGAN BANK MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 23. GLOBAL ARTIFICIAL ORGAN BANK MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL ARTIFICIAL ORGAN BANK MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL HEART MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL HEART MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL HEART MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL INTESTINE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL INTESTINE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL INTESTINE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL KIDNEY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL KIDNEY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL KIDNEY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL LIVER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL LIVER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL LIVER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL LUNG MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL LUNG MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL LUNG MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL PANCREAS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL PANCREAS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL PANCREAS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL 3D BIOPRINTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL 3D BIOPRINTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL 3D BIOPRINTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL EXTRUSION BIOPRINTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL EXTRUSION BIOPRINTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL EXTRUSION BIOPRINTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL INKJET BIOPRINTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL INKJET BIOPRINTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL INKJET BIOPRINTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL LASER ASSISTED BIOPRINTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL LASER ASSISTED BIOPRINTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL LASER ASSISTED BIOPRINTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL CELL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL CELL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL CELL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL DECELLULARIZATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL DECELLULARIZATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL DECELLULARIZATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL SCAFFOLD BASED TECHNOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SCAFFOLD BASED TECHNOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SCAFFOLD BASED TECHNOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CERAMIC SCAFFOLD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CERAMIC SCAFFOLD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CERAMIC SCAFFOLD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL NATURAL POLYMER SCAFFOLD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL NATURAL POLYMER SCAFFOLD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL NATURAL POLYMER SCAFFOLD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL SYNTHETIC POLYMER SCAFFOLD MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL SYNTHETIC POLYMER SCAFFOLD MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL SYNTHETIC POLYMER SCAFFOLD MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL ALLOGENIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL ALLOGENIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL ALLOGENIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL AUTOLOGOUS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL AUTOLOGOUS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL AUTOLOGOUS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL SYNTHETIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL SYNTHETIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL SYNTHETIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL COMPOSITE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL COMPOSITE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL COMPOSITE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL POLYMER MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL POLYMER MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL POLYMER MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL RESEARCH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL RESEARCH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RESEARCH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL TRANSPLANTATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL ORGAN TRANSPLANT CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL ORGAN TRANSPLANT CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL ORGAN TRANSPLANT CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 93. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 95. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 96. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 97. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 98. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 99. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 100. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 101. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 102. ASIA-PACIFIC ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 103. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 105. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 106. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 107. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 108. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 109. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 110. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 111. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 112. EUROPE ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 113. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 115. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 116. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 117. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 118. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 119. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 120. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 121. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 122. NORTH AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 125. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 126. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 127. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 128. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 129. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 130. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 131. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 132. LATIN AMERICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 135. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 136. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 137. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 138. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 139. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 140. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 141. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 142. AFRICA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 143. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 144. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 145. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 146. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 147. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 148. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 149. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 150. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 151. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 152. MIDDLE EAST ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 154. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 155. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 156. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 157. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 158. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 159. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 160. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 161. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 162. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 163. NATO ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 164. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 166. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 167. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 168. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 169. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 170. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 171. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 172. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 173. G7 ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 174. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 175. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 176. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 177. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 178. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 180. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 181. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 182. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 183. BRICS ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 189. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 190. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 191. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 192. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 193. EUROPEAN UNION ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 194. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 195. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 196. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 197. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 198. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 199. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 200. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 201. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 202. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 203. ASEAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 204. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 205. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 206. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 207. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 208. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 209. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 210. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 211. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 212. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 213. GCC ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. GLOBAL ARTIFICIAL ORGAN BANK MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 215. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 216. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 217. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 218. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 219. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 220. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 221. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 222. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 223. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 224. CHINA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 225. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 226. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 227. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 228. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 229. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 230. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 231. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 232. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 233. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 234. UNITED STATES ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 235. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 236. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 237. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 238. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 239. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 240. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 241. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 242. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 243. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. JAPAN ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 246. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 247. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 248. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 249. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 250. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 251. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 252. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 253. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 254. INDIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 255. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 256. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 257. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 258. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 259. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 260. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 261. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 262. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 263. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 264. GERMANY ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 265. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 266. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 267. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 268. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 269. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 270. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 271. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 272. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 273. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 274. UNITED KINGDOM ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 275. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 276. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 277. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 278. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 279. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 280. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 281. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 282. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 283. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 284. AUSTRALIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 285. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 286. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 287. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 288. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 289. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 290. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 291. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 292. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 293. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 294. FRANCE ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 295. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 296. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 297. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 298. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 299. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 300. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 301. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 302. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 303. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. SOUTH KOREA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 306. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 307. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 308. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 309. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 310. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 311. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 312. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 313. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 314. ITALY ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 315. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 316. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 317. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 318. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 319. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 320. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 321. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 322. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 323. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 324. CANADA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 325. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 326. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 327. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 328. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 329. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 330. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 331. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 332. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 333. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 334. RUSSIA ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 336. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 337. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 338. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 339. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 340. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 341. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 342. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 343. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 344. BRAZIL ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 345. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 346. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 347. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 348. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 349. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 350. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 351. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOGICAL, 2017-2032 (USD MILLION)
TABLE 352. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY SYNTHETIC, 2017-2032 (USD MILLION)
TABLE 353. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 354. MEXICO ARTIFICIAL ORGAN BANK MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 355. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 356. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY ORGAN TYPE, 2017-2032 (USD MILLION)
TABLE 357. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 358. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY 3D BIOPRINTING, 2017-2032 (USD MILLION)
TABLE 359. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY SCAFFOLD BASED TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 360. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY MATERIAL TYPE, 2017-2032 (USD MILLION)
TABLE 361. SPAIN ARTIFICIAL ORGAN BANK MARKET SIZE, BY BIOLOG

Companies Mentioned

  • Abiomed, Inc.
  • Artivion, Inc.
  • Asahi Kasei Medical Co., Ltd.
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Berlin Heart GmbH
  • BiVACOR Pty Ltd
  • Boston Scientific Corporation
  • CARMAT SA
  • CELLINK AB
  • Cochlear Limited
  • CryoLife, Inc.
  • Edwards Lifesciences Corporation
  • Fresenius Medical Care AG & Co. KGaA
  • Getinge AB
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • Medtronic plc
  • Miromatrix Medical Inc.
  • Nipro Corporation
  • Organovo Holdings, Inc.
  • OrganOx Limited by Terumo Corporation
  • SynCardia Systems, LLC
  • TransMedics, Inc.
  • Xvivo Perfusion AB
  • Zimmer Biomet Holdings Inc.

Table Information

Report AttributeDetails
No. of Pages182
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.04 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.92 Billion
Compound Annual Growth Rate7.2%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Artificial Organs Market - Global Forecast 2026-2032 - Product Image

Artificial Organs Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Artificial Organ & Bionics Market - Global Forecast 2026-2032 - Product Image

Artificial Organ & Bionics Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Artificial Organs Market Size, Share, Trends and Forecast by Type and Region 2026-2034 - Product Image

Artificial Organs Market Size, Share, Trends and Forecast by Type and Region 2026-2034

  • Report
  • 148 Pages
  • Global
From
Artificial Organs and Bionics - Global Strategic Business Report - Product Image

Artificial Organs and Bionics - Global Strategic Business Report

  • Report
  • 129 Pages
  • Global
From
Artificial Organs - Global Strategic Business Report - Product Image

Artificial Organs - Global Strategic Business Report

  • Report
  • 164 Pages
  • Global
From

About the Market

The Artificial Organ Bank market is a subset of the Blood Banking industry. It focuses on the development and production of artificial organs, such as hearts, lungs, and kidneys, for transplantation. These organs are created using a variety of technologies, including 3D printing, tissue engineering, and stem cell research. The goal of the Artificial Organ Bank market is to provide a reliable source of organs for transplantation, reducing the need for organ donation and the associated risks. The Artificial Organ Bank market is highly competitive, with many companies vying for a share of the market. Some of the major players in the market include Organovo, Organ Assist, Organogenesis, and Organovo Holdings. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.